Pulse Biosciences, Inc Common Stock (DE) (PLSE) is a publicly traded Healthcare sector company. As of July 16, 2026, PLSE trades at $26.40 with a market cap of $1.76B and a P/E ratio of -24.27. PLSE moved +3.69% today. Year to date, PLSE is +91.70%; over the trailing twelve months it is +72.93%. Its 52-week range spans $12.56 to $31.00. Analyst consensus is buy with an average price target of $31.00. Rallies surfaces PLSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PLSE insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $26.40 |
| Market Cap | $1.76B |
| P/E Ratio | -24.27 |
| EPS | $-1.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.00 |
| 52-Week Low | $12.56 |
| Volume | 159.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $350.00K |
| Net Income | $-72.78M |
| Gross Margin | -54.00% |
2 analysts cover PLSE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $31.00.